Fabry Disease: Symptoms in Children and Teenagers
Author(s) -
Л. М. Кузенкова,
Leyla S. Namazova-Baranova,
Tatyana V. Podkletnova,
А. K. Gevorkyan,
Nato D. Vashakmadze,
Kirill V. Savostyanov,
В. М. Студеникин,
Stefan Pushkov
Publication year - 2015
Publication title -
вопросы современной педиатрии
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.12
H-Index - 5
eISSN - 1682-5535
pISSN - 1682-5527
DOI - 10.15690/vsp.v14i3.1369
Subject(s) - fabry disease , enzyme replacement therapy , medicine , disease , life expectancy , pediatrics , quality of life (healthcare) , lysosomal storage disease , pathology , population , nursing , environmental health
Fabry disease is a serious degenerative hereditary disorder, which is referred to as a lysosomal storage disease and is a form of sphingolipidosis. Fabry disease often starts in childhood and adolescence, although the complete clinical manifestation occurs in adulthood. Early diagnostic is often difficult due to polymorphic clinical picture, untypical initial symptoms and doctors’ low level of awareness. Fabry disease patients should undergo a special kind of pathogenetic enzyme replacement therapy. Timely diagnosis and prompt treatment can prolong life expectancy and improve life quality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom